{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:30:00Z","timestamp":1775251800862,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003484","name":"Heinrich Heine University","doi-asserted-by":"publisher","award":["46-2016"],"award-info":[{"award-number":["46-2016"]}],"id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003484","name":"Heinrich Heine University","doi-asserted-by":"publisher","award":["16-2014"],"award-info":[{"award-number":["16-2014"]}],"id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003484","name":"Heinrich Heine University","doi-asserted-by":"publisher","award":["32-2018"],"award-info":[{"award-number":["32-2018"]}],"id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijcard.2018.10.040","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T16:54:23Z","timestamp":1539708863000},"page":"95-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation"],"prefix":"10.1016","volume":"275","author":[{"given":"Lisa","family":"Dannenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Mourikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saif","family":"Zako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Helten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"M'Pembele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajetan","family":"Trojovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Konsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodo","family":"Levkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcard.2018.10.040_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2018.10.040_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjmed.2009.12.013","article-title":"Improving stroke risk stratification in atrial fibrillation","volume":"123","author":"Lip","year":"2010","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2018.10.040_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pcad.2015.07.003","article-title":"Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk","volume":"58","author":"Potpara","year":"2015","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2018.10.040_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2017.08.011","article-title":"International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries","volume":"194","author":"Steinberg","year":"2017","journal-title":"Am. Heart J."},{"issue":"24","key":"10.1016\/j.ijcard.2018.10.040_bb0025","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.10.040_bb0030","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","article-title":"The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with Atrial Fibrillation) trial","volume":"151","author":"Fountain","year":"2006","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2018.10.040_bb0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"issue":"9689","key":"10.1016\/j.ijcard.2018.10.040_bb0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcard.2018.10.040_bb0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00399-017-0537-8","article-title":"Oral anticoagulation and platelet inhibition after atrial appendage occlusion","volume":"28","author":"Bergmann","year":"2017","journal-title":"Herzschrittmacherther. Elektrophysiol."},{"issue":"10","key":"10.1016\/j.ijcard.2018.10.040_bb0050","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/europace\/eux254","article-title":"Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey","volume":"19","author":"Tilz","year":"2017","journal-title":"Europace"},{"issue":"17","key":"10.1016\/j.ijcard.2018.10.040_bb0055","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2016.08.016","article-title":"Single antiplatelet therapy following left atrial appendage closure in patients with contraindication to anticoagulation","volume":"68","author":"Rodriguez-Gabella","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.10.040_bb0060","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.ijcard.2018.10.040_bb0065","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.10.040_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thromres.2015.12.021","article-title":"Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention","volume":"138","author":"Komosa","year":"2016","journal-title":"Thromb. Res."},{"issue":"7637","key":"10.1016\/j.ijcard.2018.10.040_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ijcard.2018.10.040_bb0080","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the gauging responsiveness with a VerifyNow P2Y12 assay: impact on thrombosis and safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.10.040_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2015.01.028","article-title":"High on-treatment platelet reactivity in transcatheter aortic valve implantation patients","volume":"751","author":"Polzin","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.10.040_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/09537104.2015.1096335","article-title":"Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale\/atrium septum defect closure","volume":"27","author":"Polzin","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.ijcard.2018.10.040_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vph.2015.07.015","article-title":"Platelet reactivity in MitraClip patients","volume":"77","author":"Polzin","year":"2016","journal-title":"Vasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.10.040_bb0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.thromres.2011.07.022","article-title":"CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention","volume":"129","author":"Kassimis","year":"2012","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.ijcard.2018.10.040_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jth.13211","article-title":"Antiplatelet effects of aspirin in chronic kidney disease patients","volume":"14","author":"Polzin","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.ijcard.2018.10.040_bb0110","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jacc.2013.07.039","article-title":"Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease","volume":"62","author":"Polzin","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2018.10.040_bb0115","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.10.040_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/bmm.10.122","article-title":"Functional testing methods for the antiplatelet effects of aspirin","volume":"5","author":"Schror","year":"2011","journal-title":"Biomark. Med"},{"issue":"3","key":"10.1016\/j.ijcard.2018.10.040_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12975-016-0457-7","article-title":"Troponin T in prediction of culprit lesion coronary artery disease and 1-year major adverse cerebral and cardiovascular events in patients with acute stroke","volume":"7","author":"Zeus","year":"2016","journal-title":"Transl Stroke Res"},{"issue":"9683","key":"10.1016\/j.ijcard.2018.10.040_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(09)60738-8","article-title":"Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial","volume":"374","author":"Mega","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijcard.2018.10.040_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacc.2013.02.089","article-title":"Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy","volume":"62","author":"Urena","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2018.10.040_bb0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.thromres.2013.12.002","article-title":"Clopidogrel high-on-treatment platelet reactivity in acute ischemic stroke patients","volume":"133","author":"Meves","year":"2014","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.ijcard.2018.10.040_bb0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11886-011-0206-1","article-title":"Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance","volume":"13","author":"Hulot","year":"2011","journal-title":"Curr. Cardiol. Rep."},{"issue":"14","key":"10.1016\/j.ijcard.2018.10.040_bb0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2018.10.040_bb0155","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjcard.2011.11.049","article-title":"Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting","volume":"109","author":"Toma","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"19","key":"10.1016\/j.ijcard.2018.10.040_bb0160","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2018.10.040_bb0165","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/jth.12907","article-title":"High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis","volume":"13","author":"Lemesle","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ijcard.2018.10.040_bb0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/09537104.2015.1095874","article-title":"Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor","volume":"27","author":"Siller-Matula","year":"2016","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.ijcard.2018.10.040_bb0175","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1002\/ccd.26903","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer cardiac plug and the amulet","volume":"90","author":"Lempereur","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2018.10.040_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12872-016-0200-z","article-title":"Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study","volume":"16","author":"Fastner","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"issue":"10","key":"10.1016\/j.ijcard.2018.10.040_bb0185","first-page":"942","article-title":"Clinical results of left atrial appendage closure with Watchman device in patients with atrial fibrillation","volume":"98","author":"Pheerawong","year":"2015","journal-title":"J. Med. Assoc. Thail."},{"issue":"7","key":"10.1016\/j.ijcard.2018.10.040_bb0190","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.amjcard.2012.12.013","article-title":"Effect of CYP2C19*2 and *17 genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation to bleeding complications","volume":"111","author":"Grosdidier","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.10.040_bb0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijcard.2012.09.214","article-title":"Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy","volume":"168","author":"Cuisset","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2018.10.040_bb0200","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2018.10.040_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.thromres.2007.05.014","article-title":"Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score","volume":"121","author":"Poli","year":"2007","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.ijcard.2018.10.040_bb0210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cardfail.2014.08.010","article-title":"HAS-BLED and CHA(2)DS(2)-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation","volume":"20","author":"Koene","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2018.10.040_bb0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.amjcard.2018.04.006","article-title":"Meta-analysis comparing single versus dual antiplatelet therapy following transcatheter aortic valve implantation","volume":"122","author":"Maes","year":"2018","journal-title":"Am. J. Cardiol."},{"issue":"10087","key":"10.1016\/j.ijcard.2018.10.040_bb0220","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ijcard.2018.10.040_bb0225","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/heartjnl-2017-311818","article-title":"Subclinical leaflet thrombosis after transcatheter aortic valve implantation","volume":"103","author":"Nakatani","year":"2017","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ijcard.2018.10.040_bb0230","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/AC.68.6.8000001","article-title":"Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry","volume":"68","author":"Kefer","year":"2013","journal-title":"Acta Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.10.040_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5603\/CJ.a2017.0017","article-title":"Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet","volume":"24","author":"Kleinecke","year":"2017","journal-title":"Cardiol J"},{"issue":"31","key":"10.1016\/j.ijcard.2018.10.040_bb0240","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2018.10.040_bb0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/09537104.2010.499483","article-title":"Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy","volume":"21","author":"Armero","year":"2010","journal-title":"Platelets"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318344681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318344681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:19:46Z","timestamp":1775247586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318344681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":49,"alternative-id":["S0167527318344681"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.10.040","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}